ShangPharma Innovation Names Two Executives-In-Residence

ShangPharma Innovation Inc., a global venture capital firm and innovation incubator focused on biomedical R&D therapeutics and technologies, announced the appointment of Dirk G. Brockstedt, Ph.D., and Benson Tsang, MBA, to its Executive-In-Residence (EIR) team.

ShangPharma Innovation and SRI International Announce Drug Discovery Collaboration

ShangPharma Innovation Inc. (SPII) and SRI International today announced a strategic collaboration to accelerate the development of innovative pharmaceuticals targeting neuroinflammation as a treatment for Alzheimer’s and other diseases.